Efficacy and Safety of Pivekimab Sunirine (PVEK) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in the CADENZA Study
Year: 2025
Type: conference-paper
Authors: Pemmaraju, Naveen, Marconi, Giovanni, Montesinos, Pau, A. Lane, Andrew, Mazzarella, Luca, Andrew Sallman, David, Ulrickson, Matthew, J. Schiller, Gary, Paul Erba, Harry, S. Wang, Eunice, B. Walter, Roland, Deconinck, Eric, M. Aribi, Ahmed, Legrand, Ollivier, Lebon, Delphine, Martinelli, Giovanni, J. Deangelo, Daniel, Du, Yining, Potluri, Jalaja, Guastad Daver, Naval
Institutions: The University of Texas MD Anderson Cancer Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Hospital Universitari i Politècnic La Fe, European Institute of Oncology, Banner MD Anderson Cancer Center at Banner North Colorado Medical Center, Centre Hospitalier Universitaire de Besançon, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, Centre Hospitalier Universitaire Amiens-Picardie, Hématopoïèse et immunologie, Université de Picardie Jules Verne, AbbVie (United States)
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7125568059
FWCI:
Cites:
Cited by:
Related to: